Orange Book product · Brand (NDA)

ANGELIQ

DROSPIRENONE; ESTRADIOL

Brand (NDA)NDA 021355RX BAYER HLTHCARE

Feb 29, 2012

Approved

Brand (NDA)

Application

Not listed

TE code

Listed patents

Approval
FDA approval date of this drug product.
Feb 29, 2012
14 yr 6 mo ago
Today
Patent 8906890 expires
Listed drug product patent expiration.
Oct 22, 2031
in 5 yr 5 mo

Active ingredient

DROSPIRENONE; ESTRADIOL

Strength

0.25MG;0.5MG

Dosage form

TABLET

Route

ORAL

TE code

Not listed

Application

NDA 021355

Product number

001

Marketing status

Reference listed drug (RLD)

Yes

Reference standard (RS)

Active-ingredient family

This is a reference-listed drug (RLD) — the basis for generic (ANDA) applications. Other products sharing this ingredient are listed below.

Patents listed in the FDA Orange Book for this product, with expiration date and patent type.
Patent	Expires	In	Type
8906890	Oct 22, 2031	in 5 yr 5 mo	Product